Crestline Management’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
2024
Q4
$8.27M Buy
2024
Q3
$6.12M Buy
2020
Q3
Sell
2020
Q2
$221K Buy